Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

BIOGEN, INC.

Filed by FEDERAL STREET STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 22, 2025
Income
$50,000.00
Expenses
Not reported
Filing UUID
1f4d0224-6876-4323-936d-9992e555d771
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Monitoring issues related to Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment. Monitor issues related to the FY2025 budget reconciliation process

MMM · Medicare/Medicaid

Issues related to rare diseases and treatment. Issues related to Mental Health treatment. Issues related to maternal health. Monitor issues related to the FY2025 budget reconciliation process

TAX · Taxation/Internal Revenue Code

Issues related to tax reform and the FY2025 budget reconciliation process

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.